Mbarara University Teaching Hospital
Mbarara, Uganda
NCT Number: NCT01140633
Current measures of adherence detect problems weeks to months after they occur. Because the HIV virus rapidly begins replicating and mutating in the absence of effective antiretroviral therapy, treatment failure may develop before an intervention can be deployed. Real-time objective adherence monitoring could redirect efforts from a reactive response to the proactive prevention of treatment failure. Because adherence is so closely associated with viral suppression, accurate adherence monitoring could also strategically limit viral monitoring only to those patients at a defined risk for viral rebound.
This observational study is assessing a wireless adherence monitoring device and mobile phone-based adherence data collection among caregivers of children under the age of ten years in Mbarara, Uganda. It involves both quantitative and qualitative measures of the feasibility and acceptability of these measures, as well as circumstances of adherence lapses and other individual and cultural factors affecting adherence. The qualitative data will be used to explore models of adherence behavior, which will likely include the child-caregiver dynamic, the child's mental and physical health, and social support mechanism.
Looking for future studies?
Notify Me1 year–10 year
All sexes
Observational
Mbarara, Uganda
See above.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Monthly adherence levels will be determined over the six-month study period.
Distribution of adherence based on wireless adherence monitoring devices and interactive voice response (IVR) or short message service (SMS) self report by caregivers of HIV-infected children under ten years old in Mbarara, Uganda.
Time frame: Assessments will be made a the one-month time point.
Quantitive rating and qualitative description of the feasibility and acceptability of wireless adherence measures
Time frame: Data collected at baseline and during adherence interruptions will be analyzed at the end of the six-month study period.
Qualitative data will be used to explore a theoretical model of adherence behavior among young children in a rural African setting
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04373551
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Birmingham, Alabama, United States
View Trial DetailsNCT03919695
Acquired Immunodeficiency Syndrome, Alcohol Use Disorder
Multiple Locations, Wakiso District, Uganda
View Trial DetailsNCT03403569
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Fuzhou, Fujian, China
View Trial DetailsNCT04371835
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Buenos Aires, Buenos Aires F.D., Argentina
View Trial Details